13th Biennial Thyroid Update 2021

13th Biennial Thyroid Update 2021

13th Biennial Thyroid Update 2021 has transitioned to a virtual meeting! We are delighted to bring you updates in thyroid conditions such as hypothyroidism, hyperthyroidism, thyroid nodules and thyroid cancers. This program aims to clarify the important issues surrounding the diagnosis and management of these common thyroid disorders. Guidelines on hypothyroidism, thyroid nodules as well as well-differentiated, medullary thyroid cancer and anaplastic thyroid cancer have been recently updated.

• This conference will utilize and encourage the use of a multidisciplinary approach to educate clinicians about current and controversial issues in thyroid disease and will provide an opportunity for providers to become familiar with the key elements of the updated guidelines and incorporate them into their clinical practice.

Include: 15 videos + 1 pdf, size: 3.17 GB

Target Audience: Endocrinology, Diabetes and Metabolism, Nuclear Medicine, Oncology, Otolaryngology, Pathology, Radiation Oncology, Radiology, Surgery

 Topics:

• 13th Biennial Thyroid Update 2021.pdf
• Session I and Session II Panel Discussion.mp4
• Session I Intro and Thyroid-Associated Ophthalmopathy From Bench to Bedside.mp4
• Session I Management of Hypothyroidism Beyond the Levothyroxine You Know.mp4
• Session I Modern Evaluation and Management of Thyroid Nodules.mp4
• Session I Thyroid Disorders and Pregnancy.mp4
• Session II Intro and The Future of Thyroid Surgery.mp4
• Session III and IV Panel Discussion and Closing Remarks.mp4
• Session III Debate Active Surveillance vs. I-131 Therapy for Low Intermediate Risk Papillary Thyroid Cancer – Douglas Van Nostrand.mp4
• Session III Debate Active Surveillance vs. I-131 Therapy for Low Intermediate Risk Papillary Thyroid Cancer – Leonard Wartofsky.mp4
• Session III Debate Active Surveillance vs. I-131 Therapy for Low Intermediate Risk Papillary Thyroid Cancer – R. Michael Tuttle.mp4
• Session III Graves Disease The Nuclear Medicine Perspective.mp4
• Session III Intro and Graves Disease The Medical Perspective.mp4
• Session IV Advances in the Treatment of Anaplastic Thyroid Cancer.mp4
• Session IV Intro and Precision Medicine in the Treatment of Differentiated Thyroid Cancer.mp4
• Session IV Targeting RET in Medullary Thyroid Cancer.mp4

Objectives

1. Evaluate and compare the available molecular tests for thyroid nodules to determine which patients require thyroid surgery and which patients can be monitored.
2. Incorporate an interdisciplinary approach to the diagnosis and management of patients with thyroid disease.
3. Evaluate and select newly approved targeted oral chemotherapy agents for the treatment of locally advanced or metastatic thyroid cancer refractory to radioiodine therapy.
4. Utilize stratified risk assessment for thyroid cancer.
5. Identify proper thyroid cancer patient selection for monitoring, lobectomy, or total thyroidectomy.
6. Implement American Thyroid Association Guideline recommendations for evaluation and management of thyroid nodules and thyroid cancer.
7. Evaluate when to use tissue genotyping in the management of advanced thyroid cancer.
8. Integrate a team-based approach in the care of patients with thyroid cancer.
9. Identify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with thyroid cancer.